Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Johannes M. Mommers"'
Autor:
Tamara W. van Hal, Juul M. P. A. van den Reek, Mark H. Wenink, Marisol E. Otero, Paul M. Ossenkoppele, Marcellus D. Njoo, Annet Oostveen, Bas Peters, Milan Tjioe, Else N. Kop, John E. M. Körver, Sharon R. P. Dodemont, Marloes M. Kleinpenning, Maartje A. M. Berends, Wendelien R. Veldkamp, Martijn B. A. van Doorn, Johannes M. Mommers, Robert-Jan Lindhout, Astrid L. A. Kuijpers, Paula P. van Lümig, C. (Els) J. de Jonge, Ron A. Tupker, Judith Hendricksen, Romy R. Keijsers, Frank H. J. van den Hoogen, Johanna E. Vriezekolk, Elke M. G. J. de Jong
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
AbstractBackground: Little is known about the extent of impairments in work and activities of daily life (ADL) in patients with psoriasis, and the influence of contextual factors such as disease-related characteristics and treatment. Therefore, this
Externí odkaz:
https://doaj.org/article/a0ecbd2dbd2848a58e15cb47119ba98d
Autor:
Lara S. van derSchoot, Hans J. M. M. Groenewoud, Marleen M. H. J. vanGelder, Marisol E. Otero, W. Peter Arnold, Maartje A. M. Berends, Marjolein S. De Bruin‐Weller, Sharon R. P. Dodemont, Marloes M. Kleinpenning, Marjolein I. A. Koetsier, Else N. Kop, John E. M. Körver, Astrid L. A. Kuijpers, Paula P. vanLümig, Johannes M. Mommers, Marcellus D. Njoo, Paul M. Ossenkoppele, Ron A. Tupker, M. Birgitte Visch, Lizelotte J. M. T. Weppner‐Parren, Elke M. G. J. deJong, Juul M. P. A. van denReek
Publikováno v:
JEADV Clinical Practice, Vol 1, Iss 3, Pp 240-253 (2022)
Abstract Background Limited real‐world studies are available comparing infection risk between biologics for psoriasis. Objectives The primary aim was to determine the differential effect of currently available biologics on the risk of respiratory t
Externí odkaz:
https://doaj.org/article/51346b81a8394876a681b2a06b4be13f
Autor:
Marloes E. van Muijen, Sarah E. Thomas, Hans M.M. Groenewoud, Marisol E. Otero, Paul M. Ossenkoppele, Marcellus D. Njoo, Sharon R.P. Dodemont, Else N. Kop, Maartje A.M. Berends, Marjolein I.A. Koetsier, Johannes M. Mommers, John E.M. Körver, Ron A. Tupker, Marjolein S. de Bruin-Weller, Lizelotte J.M.T. Weppner-Parren, Bas Peters, Marloes M. Kleinpenning, Astrid L.A. Kuijpers, W. Peter Arnold, Paula P.M. van Lümig, Juul M.P.A. van den Reek, Elke M.G.J. de Jong
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Real-world evidence, directly comparing the effectiveness of interleukin (IL)17-inhibitors, IL23-inhibitors, tumour necrosis factor alpha (TNF-α)-inhibitors and an IL12/23-inhibitor in psoriasis, is scarce. The aim of this study was to directly comp
Externí odkaz:
https://doaj.org/article/e146b3b81ecf4e69ba49684069d330cc
Autor:
Selma Atalay, Juul M.P.A. van den Reek, Marisol E. Otero, Marcellus D. Njoo, Johannes M. Mommers, Paul M. Ossenkoppele, Marjolein I. Koetsier, Maartje M. Berends, Peter C.M. van de Kerkhof, Hans M.M. Groenewoud, Alfons A. den Broeder, Elke M.G.J. de Jong, Wietske Kievit
Publikováno v:
Acta Dermato-Venereologica, Vol 100, Iss 19, p adv00340 (2020)
A dose reduction strategy for adalimumab, etanercept and ustekinumab in patients with psoriasis who have stable and low disease activity has recently been compared with usual care in the CONDOR study (CONtrolled DOse Reduction) of biologics in patien
Externí odkaz:
https://doaj.org/article/f5400933dae24130a11bded79abe9536
Autor:
Selma Atalay, Sophie E. Berends, Hans M. M. Groenewoud, Ron A. A. Mathot, David M. Njoo, Johannes M. Mommers, Paul M. Ossenkoppele, Marjolein I. A. Koetsier, Maartje A. Berends, Annick de Vries, Peter C. M. van de Kerkhof, Alfons A. den Broeder, Elke M. G. J. de Jong, Juul M. P. A. van den Reek
Publikováno v:
Journal of Dermatological Treatment, 33, 5, pp. 2680-2684
Journal of Dermatological Treatment, 33, 2680-2684
Journal of dermatological treatment, 33(5), 2680-2684. Informa Healthcare
Journal of Dermatological Treatment, 33, 2680-2684
Journal of dermatological treatment, 33(5), 2680-2684. Informa Healthcare
Contains fulltext : 282879.pdf (Publisher’s version ) (Open Access) BACKGROUND: Biologics for psoriasis are registered in standard dosages. In patients with low disease activity, reduction of the dose by interval prolongation can prevent overtreatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e102a1858e331c0d723d1fe396895afe
https://pubmed.ncbi.nlm.nih.gov/35193441
https://pubmed.ncbi.nlm.nih.gov/35193441
Autor:
Lara S. van der Schoot, Hans J. M. M. Groenewoud, Marleen M. H. J. van Gelder, Marisol E. Otero, W. Peter Arnold, Maartje A. M. Berends, Marjolein S. De Bruin‐Weller, Sharon R. P. Dodemont, Marloes M. Kleinpenning, Marjolein I. A. Koetsier, Else N. Kop, John E. M. Körver, Astrid L. A. Kuijpers, Paula P. van Lümig, Johannes M. Mommers, Marcellus D. Njoo, Paul M. Ossenkoppele, Ron A. Tupker, M. Birgitte Visch, Lizelotte J. M. T. Weppner‐Parren, Elke M. G. J. de Jong, Juul M. P. A. van den Reek
Publikováno v:
JEADV : Journal of the European Academy of Dermatology and Venereology, 1, 240-253
JEADV : Journal of the European Academy of Dermatology and Venereology, 1, 3, pp. 240-253
JEADV : Journal of the European Academy of Dermatology and Venereology, 1, 3, pp. 240-253
Contains fulltext : 287331.pdf (Publisher’s version ) (Open Access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f348380223c4d0137af98a2f05c46a4c
http://hdl.handle.net/2066/287331
http://hdl.handle.net/2066/287331
